Clinical Trials Logo

Thyroid Cancer clinical trials

View clinical trials related to Thyroid Cancer.

Filter by:

NCT ID: NCT03483337 Recruiting - Clinical trials for Head and Neck Cancer

New MRI Biomarkers in Head and Neck Cancers

Start date: March 16, 2018
Phase:
Study type: Observational

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

NCT ID: NCT03475953 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

REGOMUNE
Start date: May 4, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Assessment of the efficacy and safety of Regorafenib and Avelumab in patients with advanced or metastatic solid tumors (ten cohorts), once the Recommanded Phase II Dose (RP2D) has been determined (phase I trial). Assessement of the efficacy and safety of a low-dose of regorafenib (80mg/day) with avelumab in patients with advanced or metastatic colorectal tumors.

NCT ID: NCT03454464 Recruiting - Thyroid Cancer Clinical Trials

Evaluation of Central Compartment Dissection Without Thyroidectomy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

In accordance with the current guidelines,papillary thyroid microcarcinoma such as turmo invasive nerve or trachea, requires total thyroidectomy for follow-up iodine-131 treatment.In the course of clinical work, if the patient can achieve R0 resection, most of the patients do not need iodine-131 treatment,Therefore, there is no need to continue total thyroidectomy.To evaluate the practicable, thoroughness and Clinical value of bilateral central compartment dissection while preserve contrary thyroid glands.

NCT ID: NCT03432299 Recruiting - Thyroid Cancer Clinical Trials

Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma

RFAforPTMC
Start date: April 16, 2018
Phase: N/A
Study type: Interventional

This is a single center prospective clinical trial with regard to efficacy and safety of radiofrequency ablation of papillary thyroid microcarcinoma.

NCT ID: NCT03411187 Recruiting - Thyroid Cancer Clinical Trials

Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Endoscopic thyroidectomy developed rapidly in recent years, and the most popular surgical approach was endoscopic thyroidectomy by bilateral areola approach, but some operative steps was required optimization. One of the most annoying problem was the smog blurring endoscopic lens during surgery. The researcher summarized a set of convenient foot-control exhaust method and carried out this prospective study.

NCT ID: NCT03377829 Recruiting - Thyroid Cancer Clinical Trials

A Multicenter Trial of PLA vs. Surgery for Treating PTMC

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

This is a multicenter prospective controlled trial of percutaneous laser ablation(PLA) versus conventional surgery for the treatment of papillary thyroid microcarcinoma (PTMC).

NCT ID: NCT03375931 Recruiting - Thyroid Cancer Clinical Trials

The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy

Start date: December 15, 2017
Phase: N/A
Study type: Interventional

physiological end-point, incidence of adverse events, and changes in psychological status. In the past, physiological goals, major morbidity and mortality were used as indicators of recovery after surgery. However, major morbidity and mortality rates were extremely low due to the development of surgery and anesthesia techniques, and measurements of these indicators do not adequately reflect postoperative recovery. On the other hand, the measurement of the patient's health status or quality of life has become an important metric in many clinical studies. The Quality of Recovery 40 Questionnaire (QoR-40) is a multidimensional tool that specifically assesses and develops anesthetic and postoperative health conditions. Severance Hospital is conducting an anesthesiologist-led prayer for the patient only for the desired patient before anesthesia. Although it may be expected that this preoperative airway may improve the quality of recovery after anesthesia / surgery by reducing patient anxiety, there is no objective study on this. The aim of this study was to investigate the effect of preoperative preoperative airway on the quality of postoperative recovery in patients who underwent thyroidectomy for thyroid cancer. I want to see. In addition, we will investigate whether preoperative airway affects sympathetic nervous system during surgery.

NCT ID: NCT03360890 Recruiting - Thyroid Cancer Clinical Trials

Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

iPRIME
Start date: March 26, 2018
Phase: Phase 2
Study type: Interventional

Phase II, 2-cohort, single arm trial treated with the combination of the following two agents: 1. Pembrolizumab (MK3475) 200mg, every three weeks, iv 2. Docetaxel 75mg/m2, every three weeks, iv

NCT ID: NCT03300765 Recruiting - Thyroid Cancer Clinical Trials

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Start date: July 1, 2017
Phase: Phase 2
Study type: Interventional

To determine the efficacy and safety of intensity modulated radiation therapy combined with apatinib for inoperable or iodine refractory thyroid cancer.

NCT ID: NCT03268785 Recruiting - Thyroid Cancer Clinical Trials

Intra-operative Rapid Identification of Lymph Node and Parathyroid

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

During surgery, a fine needle puncture was proceeded when suspicious nodes was found by clinician. Repeat the punction for 2-3 times from different orientation and then, Diff-quik staining or PTH immunochromatographic assay were proceeded for lymph node or parathyroid glands identification. Post-operative pathology outcome was considered as golden standard.